drugset / Trial / NCT05575180

Effect of Acetazolamide and Methazolamide on Hypoxic Exercise Performance

NCT05575180

RandomizedCrossoverDouble-blindBasic science

Summary

A single-centered randomized doubled blinded placebo-controlled cross-over trial comparing two the effect of two carbonic anhydrase inhibitors on exercise performance in acute hypoxia. Participants will be young (under 40 years of age), healthy males and females who are regularly physically active.

Timeline

Start
2023-08-11
Primary completion
2024-02-22
Completion
2024-02-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetazolamide Small molecule 250 mg Oral
Subject Methazolamide Small molecule 100 mg Oral

Indications